FibroGen Market Cap

FibroGen has a market cap or net worth of 56.27 million as of February 21, 2025. Its market cap has decreased by -62.29% in one year.

Market Cap

56.27M

Enterprise Value

59.39M

Revenue

134.31M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.68

Market Cap Chart

Since November 14, 2014, FibroGen's market cap has decreased from 1.25B to 56.27M, a decrease of -95.48%. That is a compound annual growth rate of -26.02%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	56.27M	32.03%
Dec 31, 2024	42.62M	-37.71%
Dec 29, 2023	68.43M	-94.52%
Dec 30, 2022	1.25B	29.40%
Dec 31, 2021	965.40M	-60.95%
Dec 31, 2020	2.47B	-12.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.71B
GSK plc	58.32B
Haleon	34.94B
Smith & Nephew	8.87B
Hikma Pharmaceuticals	5.06B
ConvaTec Group	4.94B
HUTCHMED (China)	2.19B
Oxford Nanopore Technologies	1.26B

Market Cap Rankings